(Q35552591)

8 August 2017

1 reference

title

Development of HPV vaccines for HPV-associated head and neck squamous cell carcinoma (English)

1 reference

8 August 2017

Development of HPV Vaccines for HPV-associated Head and Neck Squamous Cell Carcinoma (English)

1 reference

https://api.crossref.org/works/10.1177/154411130301400505

18 March 2024

1 reference

Kalpana Devaraj

1

1 reference

8 August 2017

T-C Wu

3

1 reference

8 August 2017

Maura L. Gillison

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14530303

18 March 2024

language of work or name

English

0 references

publication date

1 January 2003

1 reference

full work available at URL

8 August 2017

http://cro.sagepub.com/content/14/5/345.full.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14530303

http://journals.sagepub.com/doi/pdf/10.1177/154411130301400505

18 March 2024

1 reference

https://api.crossref.org/works/10.1177/154411130301400505

http://journals.sagepub.com/doi/full-xml/10.1177/154411130301400505

18 March 2024

1 reference

https://api.crossref.org/works/10.1177/154411130301400505

Journal of Dental Research

18 March 2024

published in

1 reference

Critical Reviews in Oral Biology and Medicine

8 August 2017

14

5

345–62

2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14530303

18 March 2024

volume

14

1 reference

8 August 2017

5

1 reference

8 August 2017

345-362

1 reference

Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer.

8 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenge with a high dose of SHIV-4 virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Enhancing immune responses using suicidal DNA vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Construction and characterisation of a recombinant vaccinia virus expressing human papillomavirus proteins for immunotherapy of cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Human papillomavirus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Origin, maturation and antigen presenting function of dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Antigen-specific cancer immunotherapy using a GM-CSF secreting allogeneic tumor cell-based vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Enhancement of Sindbis virus self-replicating RNA vaccine potency by linkage of Mycobacterium tuberculosis heat shock protein 70 gene to an antigen gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Enhancement of sindbis virus self-replicating RNA vaccine potency by targeting antigen to endosomal/lysosomal compartments

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Cancer immunotherapy using Sindbis virus replicon particles encoding a VP22-antigen fusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Efficient generation of cytotoxic T lymphocytes against cervical cancer cells by adeno-associated virus/human papillomavirus type 16 E7 antigen gene transduction into dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Immunotherapy of a human papillomavirus (HPV) type 16 E7-expressing tumour by administration of fusion protein comprising Mycobacterium bovis bacille Calmette-Guérin (BCG) hsp65 and HPV16 E7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Gene vaccination with naked plasmid DNA: mechanism of CTL priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Genetic immunization against cervical carcinoma: induction of cytotoxic T lymphocyte activity with a recombinant alphavirus vector expressing human papillomavirus type 16 E6 and E7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Oral somatic transgene vaccination using attenuated S. typhimurium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Marek's disease virus (MDV) homologues of herpes simplex virus type 1 UL49 (VP22) and UL48 (VP16) genes: high-level expression and characterization of MDV-1 VP22 and VP16.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Intercellular trafficking and protein delivery by a herpesvirus structural protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Peptide polymerisation facilitates incorporation into ISCOMs and increases antigen-specific IgG2a production

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Changing patterns of tonsillar squamous cell carcinoma in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Immune response to human papillomavirus type 16 E6 gene in a live vaccinia vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Human papillomavirus virus-like particles are efficient oral immunogens when coadministered with Escherichia coli heat-labile enterotoxin mutant R192G or CpG DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Human papillomavirus in head and neck squamous cell carcinoma: are some head and neck cancers a sexually transmitted disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Evidence for a causal association between human papillomavirus and a subset of head and neck cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors im

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Immunization of mice with HPV vaccinia virus recombinants generates serum IgG, IgM, and mucosal IgA antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Interleukin-12-secreting human papillomavirus type 16-transformed cells provide a potent cancer vaccine that generates E7-directed immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Improving vaccine potency through intercellular spreading and enhanced MHC class I presentation of antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Improving DNA vaccine potency by linking Marek's disease virus type 1 VP22 to an antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Immune responses induced by BCG recombinant for human papillomavirus L1 and E7 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Chimeric virus-like particles of the human papillomavirus type 16 (HPV 16) as a prophylactic and therapeutic vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Sites of predilection in recurrent respiratory papillomatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Nasal immunization of mice with peptide having a cross-neutralization epitope on minor capsid protein L2 of human papillomavirus type 16 elicit systemic and mucosal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

A controlled trial of a human papillomavirus type 16 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Induction of an antibody response in mice against human papillomavirus (HPV) type 16 after immunization with HPV recombinant Salmonella strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Genital papillomavirus infection and cervical dysplasia--opportunistic complications of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Regression of established human papillomavirus type 16 (HPV-16) immortalized tumors in vivo by vaccinia viruses expressing different forms of HPV-16 E7 correlates with enhanced CD8(+) T-cell responses that home to the tumor site

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Granulocyte-macrophage colony-stimulating factor priming plus papillomavirus E6 DNA vaccination: effects on papilloma formation and regression in the cottontail rabbit papillomavirus--rabbit model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Ubiquitin-fused and/or multiple early genes from cottontail rabbit papillomavirus as DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Effective vaccination against papilloma development by immunization with L1 or L2 structural protein of cottontail rabbit papillomavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Recombinant adeno-associated virus expressing human papillomavirus type 16 E7 peptide DNA fused with heat shock protein DNA as a potential vaccine for cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Polynucleotide viral vaccines: codon optimisation and ubiquitin conjugation enhances prophylactic and therapeutic efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Rapid induction of cytotoxic T-cell response against cervical cancer cells by human papillomavirus type 16 E6 antigen gene delivery into human dendritic cells by an adeno-associated virus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Immunisation of mice using Salmonella typhimurium expressing human papillomavirus type 16 E7 epitopes inserted into hepatitis B virus core antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Human papillomavirus type 11 (HPV-11) neutralizing antibodies in the serum and genital mucosal secretions of African green monkeys immunized with HPV-11 virus-like particles expressed in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Bone marrow-derived dendritic cells serve as potent adjuvants for peptide-based antitumor vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Immunization against human papillomavirus type 16 tumor cells with recombinant vaccinia viruses expressing E6 and E7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Viral etiology of juvenile- and adult-onset squamous papilloma of the larynx

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Human papillomavirus type 16 immortalized cervical keratinocytes contain transcripts encoding E6, E7, and E2 initiated at the P97 promoter and express high levels of E7

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

A DNA vaccine based on a shuffled E7 oncogene of the human papillomavirus type 16 (HPV 16) induces E7-specific cytotoxic T cells but lacks transforming activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Dendritic Cells as Carriers for a Cytotoxic T-Lymphocyte Epitope-Based Peptide Vaccine in Protection Against a Human Papillomavirus Type 16-Induced Tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC class I pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Stable alphavirus packaging cell lines for Sindbis virus and Semliki Forest virus-derived vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Mucosal vaccination with a recombinant Salmonella typhimurium expressing human papillomavirus type 16 (HPV16) L1 virus-like particles (VLPs) or HPV16 VLPs purified from insect cells inhibits the growth of HPV16-expressing tumor cells in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Nucleic acid vaccines: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Assembly of human papillomavirus type 16 pseudovirions in Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Human dendritic cells are activated by chimeric human papillomavirus type-16 virus-like particles and induce epitope-specific human T cell responses in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Synthesis and assembly of virus-like particles of human papillomaviruses type 6 and type 16 in fission yeast Schizosaccharomyces pombe

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

The increased frequency of cervical dysplasia-neoplasia in women infected with the human immunodeficiency virus is related to the degree of immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Immune response to human papillomavirus 16 L1E7 chimeric virus-like particles: induction of cytotoxic T cells and specific tumor protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Efficiency of peptides and lipopeptides for in vivo priming of virus-specific cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Papillomavirus-like particle vaccines for cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Human papillomavirus infection and survival in oral squamous cell cancer: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Structure and transcription of human papillomavirus sequences in cervical carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Risk factors for juvenile onset recurrent respiratory papillomatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Modified HPV16 E7 Genes as DNA Vaccine against E7-Containing Oncogenic Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Human papillomavirus (HPV) type 16 and 33 E6/E7 region transcripts in tonsillar carcinomas can originate from integrated and episomal HPV DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Heat shock protein-peptide complexes in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Intra-epithelial vaccination with COPV L1 DNA by particle-mediated DNA delivery protects against mucosal challenge with infectious COPV in beagle dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Interleukin-12 cDNA skin transfection potentiates human papillomavirus E6 DNA vaccine-induced antitumor immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

A vaccine conjugate of 'ISCAR' immunocarrier and peptide epitopes of the E7 cervical cancer-associated protein of human papillomavirus type 16 elicits specific Th1- and Th2-type responses in immunized mice in the absence of oil-based adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

In vitro gene transfer using human papillomavirus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Genetically modified bone marrow-derived dendritic cells expressing tumor-associated viral or "self" antigens induce antitumor immunity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Natural T-helper immunity against human papillomavirus type 16 (HPV16) E7-derived peptide epitopes in patients with HPV16-positive cervical lesions: identification of 3 human leukocyte antigen class II-restricted epitopes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Defined flanking spacers and enhanced proteolysis is essential for eradication of established tumors by an epitope string DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Peptide vaccination with an anchor-replaced CTL epitope protects against human papillomavirus type 16-induced tumors expressing the wild-type epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Immunology of the human papilloma virus in relation to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Sindbis virus: an efficient, broad host range vector for gene expression in animal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Cancer therapy using a self-replicating RNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Synthetic peptides of human papillomavirus type 18 E6 harboring HLA-A2.1 motif can induce peptide-specific cytotoxic T-cells from peripheral blood mononuclear cells of healthy donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Immunization with a pentameric L1 fusion protein protects against papillomavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Papillomaviruses and cancer: from basic studies to clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F154411130301400505

Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions

21 January 2018

4

1 reference

https://api.crossref.org/works/10.1177/154411130301400505

Identification in humans of HPV-16 E6 and E7 protein epitopes recognized by cytolytic T lymphocytes in association with HLA-B18 and determination of the HLA-B18-specific binding motif

18 March 2024

10

1 reference

https://api.crossref.org/works/10.1177/154411130301400505

Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection.

18 March 2024

15

1 reference

https://api.crossref.org/works/10.1177/154411130301400505

Prophylactic and therapeutic vaccination against a mucosal papillomavirus

18 March 2024

17

1 reference

https://api.crossref.org/works/10.1177/154411130301400505

Antigen-specific immunotherapy for human papillomavirus 16 E7-expressing tumors grown in the liver

18 March 2024

22

1 reference

https://api.crossref.org/works/10.1177/154411130301400505

The open reading frame L2 of cottontail rabbit papillomavirus contains antibody-inducing neutralizing epitopes

18 March 2024

31

1 reference

https://api.crossref.org/works/10.1177/154411130301400505

DNA-based immunization by in vivo transfection of dendritic cells

18 March 2024

35

1 reference

https://api.crossref.org/works/10.1177/154411130301400505

Continued expression of HPV-16 E7 protein is required for maintenance of the transformed phenotype of cells co-transformed by HPV-16 plus EJ-ras.

18 March 2024

38

1 reference

https://api.crossref.org/works/10.1177/154411130301400505

18 March 2024

DNA vaccines

44

1 reference

https://api.crossref.org/works/10.1177/154411130301400505

Human papillomavirus in head and neck squamous cell carcinomas in nonsmokers

18 March 2024

51

1 reference

https://api.crossref.org/works/10.1177/154411130301400505

Therapeutic potential of protein and adjuvant vaccinations on tumour growth

18 March 2024

56

1 reference

https://api.crossref.org/works/10.1177/154411130301400505

Tumor regression in mice following vaccination with human papillomavirus E7 recombinant protein in PROVAX

18 March 2024

67

1 reference

https://api.crossref.org/works/10.1177/154411130301400505

DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector

18 March 2024

68

1 reference

https://api.crossref.org/works/10.1177/154411130301400505

Viral recombinant vaccines to the E6 and E7 antigens of HPV-16

18 March 2024

71

1 reference

https://api.crossref.org/works/10.1177/154411130301400505

Regions of human papillomavirus type 16 E7 oncoprotein required for immortalization of human keratinocytes

18 March 2024

83

1 reference

https://api.crossref.org/works/10.1177/154411130301400505

Antigen-specific immunotherapy for murine lung metastatic tumors expressing human papillomavirus type 16 E7 oncoprotein

18 March 2024

84

1 reference

https://api.crossref.org/works/10.1177/154411130301400505

Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16 E7-expressing tumors

18 March 2024

85

1 reference

https://api.crossref.org/works/10.1177/154411130301400505

Common neutralization epitope in minor capsid protein L2 of human papillomavirus types 16 and 6

18 March 2024

89

1 reference

https://api.crossref.org/works/10.1177/154411130301400505

Phase IIa safety and immunogenicity of a therapeutic vaccine, TA-GW, in persons with genital warts

18 March 2024

95

1 reference

https://api.crossref.org/works/10.1177/154411130301400505

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

18 March 2024

113

1 reference

https://api.crossref.org/works/10.1177/154411130301400505

Enhanced immunogenicity of HPV 16 E7 fusion proteins in DNA vaccination

18 March 2024

117

1 reference

https://api.crossref.org/works/10.1177/154411130301400505

A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour cell challenge and causes regression of established tumours

18 March 2024

126

1 reference

https://api.crossref.org/works/10.1177/154411130301400505

Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein

18 March 2024

129

1 reference

https://api.crossref.org/works/10.1177/154411130301400505

18 March 2024

DNA vaccines

138

1 reference

https://api.crossref.org/works/10.1177/154411130301400505

Minor capsid protein of human genital papillomaviruses contains subdominant, cross-neutralizing epitopes

18 March 2024

140

1 reference

https://api.crossref.org/works/10.1177/154411130301400505

Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit

18 March 2024

145

1 reference

https://api.crossref.org/works/10.1177/154411130301400505

Studies on in vivo induction of cytotoxic T lymphocyte responses by synthetic peptides from E6 and E7 oncoproteins of human papillomavirus type 16

18 March 2024

146

1 reference

https://api.crossref.org/works/10.1177/154411130301400505

Induction of an HPV 6bL1-specific mucosal IgA response by DNA immunization

18 March 2024

153

1 reference

https://api.crossref.org/works/10.1177/154411130301400505

Immunization with nonstructural proteins E1 and E2 of cottontail rabbit papillomavirus stimulates regression of virus-induced papillomas

18 March 2024

156

1 reference

https://api.crossref.org/works/10.1177/154411130301400505

Prevalence of mucosotropic human papillomaviruses in squamous-cell carcinoma of the head and neck

18 March 2024

162

1 reference

https://api.crossref.org/works/10.1177/154411130301400505

Regression phenomenon of numerous flat warts--an experiment on the nature of tumor immunity in man

18 March 2024

169

1 reference

https://api.crossref.org/works/10.1177/154411130301400505

Phase I safety and antigenicity of TA-GW: a recombinant HPV6 L2E7 vaccine for the treatment of genital warts

18 March 2024

172

1 reference

https://api.crossref.org/works/10.1177/154411130301400505

Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I-II trial

18 March 2024

180

1 reference

https://api.crossref.org/works/10.1177/154411130301400505

Induction of a cytolytic T-cell response in mice with a recombinant adenovirus coding for tumor antigen P815A

18 March 2024

186

1 reference

https://api.crossref.org/works/10.1177/154411130301400505

DNA packaging by L1 and L2 capsid proteins of bovine papillomavirus type 1

18 March 2024

198

1 reference

https://api.crossref.org/works/10.1177/154411130301400505

18 March 2024

Identifiers

1 reference

release_lu6dfplnyrfevph3ecahjdaakm

8 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lu6dfplnyrfevph3ecahjdaakm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference